PROVIEW-MBD Biotech focuses on smart hydrogel and polymer materials as its core technologies, dedicated to developing medical products that combine clinical value and global competitiveness.
   The company’s product portfolio covers anti-adhesion, lubrication, protection, and regenerative medicine applications, continuously enhancing healthcare quality through material innovation.

Products on the Market
​

"PROVIEW-MBD" Atamabarrier Anti-Adhesion Gel
​

MOHW-MD-(III)-No.010039
​​Product Description:
This product is a sterile, absorbable, and isotonic gel composed of polyethylene oxide (PEO) and carboxymethyl cellulose (CMC) blended with calcium chloride and sodium chloride in sterile water. It is designed for application to wound sites in the epidural space, where it forms a temporary mechanical barrier to separate opposing tissue surfaces. Atamabarrier Anti-Adhesion Gel is intended for use following spinal surgeries such as laminectomy, laminotomy, or discectomy. The gel helps reduce postoperative pain, lower the incidence of radiculopathy and lower limb weakness, and minimize the occurrence, extent, and severity of postoperative tissue adhesion.
https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=81130796-3CC6-4ED3-842E-004797FCD71C

"PROVIEW-MBD" Sedoso Patient Lubricant 
​

MOHW-MD-(I)-No.008430
​Product Description: 
This product is a hyaluronic acid–based gel lubricant intended for patient use. It is used as a vaginal lubricant to facilitate medical examination or diagnostic procedures according to clinical needs. A medical-grade lubricant for clinical examinations and treatments, formulated to reduce friction and discomfort while ensuring compliance with safety standards.

https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=308C2EBF-F7E4-4E2D-A63C-8657E67B4FFC


​Future Technology Applications
​

     In addition to the existing marketed product, PROVIEW-MBD Biotech continues to expand the applications of its Smart Hydrogel Platform Technology, integrating clinical needs with innovative material development to drive the creation of next-generation medical devices.
  1. In Vivo and In Vitro Hydrogel Lubrication System: Utilizing hyaluronic acid (HA) hydrogels and crosslinking technologies, a controllable degradation-time platform has been developed, leading to the creation of both internal and external lubrication systems.
  2. Hemostatic Powder Hydrogel System: Based on carboxymethyl cellulose (CMC) materials and hydrogel formulations, this system enables rapid hemostasis through powder forms that can be applied in minimally invasive surgeries for internal wound management.
  3. Thermosensitive Anti-Adhesion Hydrogel System: Developed using bioabsorbable, temperature-sensitive hydrogel polymers, this system integrates with minimally invasive spray devices. Through in-situ gelling mechanisms, it is applied to prevent postoperative adhesions in abdominal and uterine surgeries.
  4. Hydrogel-Based Prevention and Therapeutic System: Designed as a sprayable hydrogel with imaging visibility and thermosensitive stability, it maintains its gel state and drug-loading capability for use in preventing recurrence following tumor resection surgeries.
  5. Ultimate Objective — Regenerative Medicine Applications: Building upon patented hydrogel platform technologies, PROVIEW-MBD Biotech continues to develop minimally invasive surgical devices and tissue-repair materials using bioactive, self-healing components aimed at advancing regenerative medical applications.

Quality and International Certifications

     PROVIEW-MBD Biotech upholds the belief that “Quality is the cornerstone of clinical safety.”All products are developed and manufactured in accordance with the ISO 13485 Medical Device Quality Management System and the ISO 14971 Risk Management Standard.
    Material selection and verification procedures strictly follow the ISO 10993 Biological Evaluation of Medical Devices standard to ensure that all products meet international safety requirements.
   In addition, the company continuously promotes clinical research in compliance with ISO 14155 Clinical Investigation Standards, as well as the guidance of the TFDA and US FDA, ensuring that product development, validation, and registration processes fully conform to global medical device regulations.
    PROVIEW-MBD Biotech is committed to building a globally trusted medical brand through a rigorous quality system and strong regulatory expertise, continuously delivering safe, reliable, and innovative smart material solutions to the healthcare industry.